VERACYTE, INC. Operating Cash Flow
VERACYTE, INC. (VCYT) reported Operating Cash Flow of $81.04 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-31
- VERACYTE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $45.83M, a 36.37% increase year-over-year.
- VERACYTE, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $35.22M, a 556.75% increase year-over-year.
- VERACYTE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $52.58M, a 114.41% increase year-over-year.
- VERACYTE, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $44.76M, a 49.37% increase year-over-year.
- VERACYTE, INC. net cash provided by (used in) operating activities for fiscal 2025 was $136.31M, a 81.51% increase from fiscal 2024.
- VERACYTE, INC. net cash provided by (used in) operating activities for fiscal 2024 was $75.10M, a 69.82% increase from fiscal 2023.
- VERACYTE, INC. net cash provided by (used in) operating activities for fiscal 2023 was $44.22M, a 486.89% increase from fiscal 2022.
- VERACYTE, INC. net cash provided by (used in) operating activities for fiscal 2022 was $7.54M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $45.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $81.04M 10-Q · filed 2026-07-31 | $133.62M derived: sum of 3 quarters · filed 2026-07-31 | $178.38M derived: sum of 4 quarters · filed 2026-07-31 |
| 2026-03-31 | $35.22M 10-Q · filed 2026-05-06 | $87.80M derived: sum of 2 quarters · filed 2026-05-06 | $132.56M derived: sum of 3 quarters · filed 2026-05-06 | $166.16M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-12-31 | $52.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $97.34M derived: sum of 2 quarters · filed 2026-02-26 | $130.94M derived: sum of 3 quarters · filed 2026-07-31 | $136.31M 10-K · filed 2026-02-26 |
| 2025-09-30 | $44.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $78.36M derived: sum of 2 quarters · filed 2026-07-31 | $83.72M 10-Q · filed 2025-11-05 | $108.25M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-06-30 | $33.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $38.97M 10-Q · filed 2026-07-31 | $63.49M derived: sum of 3 quarters · filed 2026-07-31 | $93.45M derived: sum of 4 quarters · filed 2026-07-31 |
| 2025-03-31 | $5.36M 10-Q · filed 2026-05-06 | $29.89M derived: sum of 2 quarters · filed 2026-05-06 | $59.85M derived: sum of 3 quarters · filed 2026-05-06 | $89.42M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $24.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $54.49M derived: sum of 2 quarters · filed 2026-02-26 | $84.06M derived: sum of 3 quarters · filed 2026-02-26 | $75.10M 10-K · filed 2026-02-26 |
| 2024-09-30 | $29.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $59.54M derived: sum of 2 quarters · filed 2025-11-05 | $50.57M 10-Q · filed 2025-11-05 | $66.12M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $29.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $20.61M 10-Q · filed 2025-08-07 | $36.16M derived: sum of 3 quarters · filed 2026-02-26 | $50.33M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$8.97M 10-Q · filed 2025-05-08 | $6.59M derived: sum of 2 quarters · filed 2026-02-26 | $20.76M derived: sum of 3 quarters · filed 2026-02-26 | $37.43M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $15.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $29.72M derived: sum of 2 quarters · filed 2026-02-26 | $46.39M derived: sum of 3 quarters · filed 2026-02-26 | $44.22M 10-K · filed 2026-02-26 |
| 2023-09-30 | $14.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $30.84M derived: sum of 2 quarters · filed 2024-11-07 | $28.67M 10-Q · filed 2024-11-07 | $38.41M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $16.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $14.50M 10-Q · filed 2024-08-07 | $24.24M derived: sum of 3 quarters · filed 2025-02-28 | $31.27M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | -$2.17M 10-Q · filed 2024-05-08 | $7.57M derived: sum of 2 quarters · filed 2025-02-28 | $14.60M derived: sum of 3 quarters · filed 2025-02-28 | $14.23M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $9.74M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $16.77M derived: sum of 2 quarters · filed 2025-02-28 | $16.41M derived: sum of 3 quarters · filed 2025-02-28 | $7.54M 10-K · filed 2025-02-28 |
| 2022-09-30 | $7.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $6.66M derived: sum of 2 quarters · filed 2023-11-08 | -$2.21M 10-Q · filed 2023-11-08 | $6.24M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$363.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$9.23M 10-Q · filed 2023-08-09 | -$789.00K derived: sum of 3 quarters · filed 2024-02-29 | -$2.18M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$8.87M 10-Q · filed 2023-05-05 | -$426.00K derived: sum of 2 quarters · filed 2024-02-29 | -$1.82M derived: sum of 3 quarters · filed 2024-02-29 | $68.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $8.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $7.05M derived: sum of 2 quarters · filed 2024-02-29 | $8.94M derived: sum of 3 quarters · filed 2024-02-29 | -$31.62M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $494.00K derived: sum of 2 quarters · filed 2022-11-03 | -$40.07M 10-Q · filed 2022-11-03 | -$37.81M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $1.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$38.67M 10-Q · filed 2022-08-03 | -$36.41M derived: sum of 3 quarters · filed 2023-03-01 | -$34.66M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$40.56M 10-Q · filed 2022-05-04 | -$38.30M derived: sum of 2 quarters · filed 2023-03-01 | -$36.55M derived: sum of 3 quarters · filed 2023-03-01 | -$44.97M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $4.01M derived: sum of 2 quarters · filed 2023-03-01 | -$4.41M derived: sum of 3 quarters · filed 2023-03-01 | -$9.71M 10-K · filed 2023-03-01 |
| 2020-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$6.67M derived: sum of 2 quarters · filed 2021-11-09 | -$11.97M 10-Q · filed 2021-11-09 | -$10.18M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$8.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | -$13.72M 10-Q · filed 2021-07-29 | -$11.93M derived: sum of 3 quarters · filed 2022-02-28 | -$13.49M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$5.30M 10-Q · filed 2021-05-10 | -$3.51M derived: sum of 2 quarters · filed 2022-02-28 | -$5.07M derived: sum of 3 quarters · filed 2022-02-28 | -$7.52M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $1.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $234.00K derived: sum of 2 quarters · filed 2022-02-28 | -$2.22M derived: sum of 3 quarters · filed 2022-02-28 | -$3.23M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$1.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$4.01M derived: sum of 2 quarters · filed 2020-11-02 | -$5.02M 10-Q · filed 2020-11-02 | -$6.25M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | -$2.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$3.47M 10-Q · filed 2020-07-30 | -$4.69M derived: sum of 3 quarters · filed 2021-02-22 | -$6.47M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | -$1.01M 10-Q · filed 2020-05-06 | -$2.24M derived: sum of 2 quarters · filed 2021-02-22 | -$4.02M derived: sum of 3 quarters · filed 2021-02-22 | -$7.12M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | -$1.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | -$3.01M derived: sum of 2 quarters · filed 2021-02-22 | -$6.11M derived: sum of 3 quarters · filed 2021-02-22 | -$13.52M 10-K · filed 2021-02-22 |
| 2018-09-30 | -$1.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-22 | -$4.88M derived: sum of 2 quarters · filed 2019-10-22 | -$12.29M 10-Q · filed 2019-10-22 | -$18.11M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | -$3.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | -$10.51M 10-Q · filed 2019-07-30 | -$16.33M derived: sum of 3 quarters · filed 2020-02-25 | -$21.43M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$7.41M 10-Q · filed 2019-04-30 | -$13.23M derived: sum of 2 quarters · filed 2020-02-25 | -$18.33M derived: sum of 3 quarters · filed 2020-02-25 | |
| 2017-12-31 | -$5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$10.92M derived: sum of 2 quarters · filed 2020-02-25 | -$23.91M 10-K · filed 2020-02-25 | |
| 2017-09-30 | -$5.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | -$18.10M 10-Q · filed 2018-10-29 | ||
| 2017-06-30 | -$13.00M 10-Q · filed 2018-07-23 | |||
| 2016-12-31 | -$27.98M 10-K · filed 2019-02-25 | |||
| 2015-12-31 | -$26.96M 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |